Real Estate Archives - Page 3 of 26

Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Expanding Clinical Data Capabilities to Accelerate Drug Development

October 29, 2025

Boston IVF Chief Scientific Officer Denny Sakkas, PhD Receives Prestigious 2025 ASRM Distinguished Researcher Award for Lifetime Contributions to Fertility Research

October 27, 2025

Alloy Therapeutics Announces Acquisition of Spannerwerks, a Leading Provider of Drug Development Consulting Services

October 23, 2025

THIS WEEK'S STORIES

MOPIC Unveils 32-Inch Autostereoscopic 3D Display for Medical Imaging and Training

October 29, 2025

Toshiba Introduces Dual-Channel Digital Isolators for High-Speed, Stable Data Transmission in Industrial Equipment

October 28, 2025

LifeCanvas Unveils DALISPIM Open-Top Light Sheet Microscope for Next-Generation 3D Imaging

October 28, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Real Estate

Overture Life Opens First U.S. Clinical Lab and Operations Hub in Dallas as AI-Powered IVF Robotics Headquarters

PureTech Scientific Acquires Cymer Chemical’s Dayton, Tennessee Facility

Mispro Expands Cambridge Presence with New Kendall Square Vivarium

AstraZeneca Expands Texas Manufacturing Facility with $445 Million Investment

Urban Green Council Honors Suffolk Chairman and CEO John Fish for Leadership in Sustainable Building

Most Read

InterVene Receives FDA Clearance for Recana, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions

Manhattan Genomics Assembles World-Class Scientific Team to Lead a New Era of Genomic Medicine

Gut Neurons Decoded: New Study Reveals How Food Allergies and Microbes Rewire the Gut’s Nervous System

Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis

EDITOR PICKS